Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3184949

Documents

Beta release

Statistics of Dual-mTOR ihibitor rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Statistics for this year
PeriodVisitsDownloads
20242017
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0811
2024-0922
2024-1000